142 related articles for article (PubMed ID: 34648629)
21. [Comparative study between sodium stibogluconate BP 88 and meglumine antimoniate in cutaneous leishmaniasis treatment. II. Biochemical and cardiac toxicity].
Saldanha AC; Romero GA; Guerra C; Merchan-Hamann E; Macedo Vde O
Rev Soc Bras Med Trop; 2000; 33(4):383-8. PubMed ID: 10936953
[TBL] [Abstract][Full Text] [Related]
22. The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.
Moosavian SA; Fallah M; Jaafari MR
Exp Parasitol; 2019 May; 200():30-35. PubMed ID: 30898544
[TBL] [Abstract][Full Text] [Related]
23. Depot Subcutaneous Injection with Chalcone CH8-Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres as a Single-Dose Treatment of Cutaneous Leishmaniasis.
Sousa-Batista AJ; Pacienza-Lima W; Arruda-Costa N; Falcão CAB; Ré MI; Rossi-Bergmann B
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263064
[TBL] [Abstract][Full Text] [Related]
24. Erythrocyte antioxidative enzyme activities and lipid peroxidation levels in patients with cutaneous leishmaniasis.
Kocyigit A; Gurel M; Ulukanligil M
Parasite; 2003 Sep; 10(3):277-81. PubMed ID: 14535169
[TBL] [Abstract][Full Text] [Related]
25. Reactive nitrogen species induced catalases promote a novel nitrosative stress tolerance mechanism in Vibrio cholerae.
Patra SK; Samaddar S; Sinha N; Ghosh S
Nitric Oxide; 2019 Jul; 88():35-44. PubMed ID: 30981896
[TBL] [Abstract][Full Text] [Related]
26. [Successful treatment of cutaneous leishmaniasis with amphotericin B; a case of unresponsive to pentavalent antimony therapy].
Yeşilova Y; Turan E; Sürücü HA; Aksoy M; Özbilgin A
Turkiye Parazitol Derg; 2015 Mar; 39(1):63-5. PubMed ID: 25917587
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous leishmaniasis: an overview.
Hepburn NC
J Postgrad Med; 2003; 49(1):50-4. PubMed ID: 12865571
[TBL] [Abstract][Full Text] [Related]
28. Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation.
Aragão Horoiwa T; Cortez M; Sauter IP; Migotto A; Bandeira CL; Cerize NNP; de Oliveira AM
Eur J Pharm Sci; 2020 Apr; 147():105295. PubMed ID: 32145429
[TBL] [Abstract][Full Text] [Related]
29. Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways.
Bamorovat M; Sharifi I; Aflatoonian MR; Sadeghi B; Shafiian A; Oliaee RT; Keyhani A; Afshar AA; Khosravi A; Mostafavi M; Parizi MH; Khatami M; Arefinia N
Int Immunopharmacol; 2019 Apr; 69():321-327. PubMed ID: 30771740
[TBL] [Abstract][Full Text] [Related]
30. [Comparative assessment of the efficacy and toxicity of N-methyl-glucamine and BP88 sodium stibogluconate in the treatment of localized cutaneous leishmaniasis].
Deps PD; Viana MC; Falqueto A; Dietze R
Rev Soc Bras Med Trop; 2000; 33(6):535-43. PubMed ID: 11175583
[TBL] [Abstract][Full Text] [Related]
31. Radicals, Oxidative/Nitrosative Stress and Preeclampsia.
Taysi S; Tascan AS; Ugur MG; Demir M
Mini Rev Med Chem; 2019; 19(3):178-193. PubMed ID: 30324879
[TBL] [Abstract][Full Text] [Related]
32. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by Leishmania tropica: interleukin-8, monocyte chemotactic protein-1 and nitric oxide are major regulatory factors.
Kumar R; Bumb RA; Salotra P
Immunology; 2010 Jun; 130(2):193-201. PubMed ID: 20102417
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.
Brito NC; Rabello A; Cota GF
PLoS One; 2017; 12(9):e0184777. PubMed ID: 28926630
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous leishmaniasis in an immigrant Saudi worker: a case report.
Rahman H; Razzak MA; Chanda BC; Bhaskar KR; Mondal D
J Health Popul Nutr; 2014 Jun; 32(2):372-6. PubMed ID: 25076674
[TBL] [Abstract][Full Text] [Related]
36. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
37. Experience with New World cutaneous leishmaniasis in travelers.
Scope A; Trau H; Anders G; Barzilai A; Confino Y; Schwartz E
J Am Acad Dermatol; 2003 Oct; 49(4):672-8. PubMed ID: 14512915
[TBL] [Abstract][Full Text] [Related]
38. Experimental treatment with sodium stibogluconate of hamsters infected with Leishmania (Leishmania) chagasi and Leishmania (Leishmania) amazonensis.
de Figueiredo EM; Costa e Silva J; Brazil RP
Rev Soc Bras Med Trop; 1999; 32(2):191-3. PubMed ID: 10228371
[TBL] [Abstract][Full Text] [Related]
39. Disruption of redox homeostasis and histopathological alterations caused by in vivo intrastriatal administration of D-2-hydroxyglutaric acid to young rats.
da Rosa MS; Seminotti B; Amaral AU; Parmeggiani B; de Oliveira FH; Leipnitz G; Wajner M
Neuroscience; 2014 Sep; 277():281-93. PubMed ID: 25043325
[TBL] [Abstract][Full Text] [Related]
40. [Effect of exogenous nitric oxide on antioxidants from mice infected with
Xiao-Li W; Liang L; Hui Z; Xing W; Zhi-Yong T; Hui X; Yuan-Yuan W; Xiao-di Y; Qiang F
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2016 Dec; 29(1):48-52. PubMed ID: 29469386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
